Individuals Stopping Weight-Loss Medications Put On Weight Far More Rapidly Than Those on Conventional Diets

New research reveals that patients who stop using new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds far faster than those who end traditional diet and exercise plans.

Published data in a prominent health publication shows that while overweight people can lose a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such drugs must be cognizant of the risk of quick weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.

This pace of recovery means a return to pre-treatment weight in about 18 months.

Comparing Approaches

The analysis, which reviewed dozens of trials involving thousands of participants, compared the outcomes of the injectable medications with other pills.

The team emphasize that people who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—approximately 100 grams monthly—once they finish.

Explaining the Rapid Rebound

Nutrition scientists believe the mechanism of the drugs is key to understanding the amplified weight return.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication results in appetite is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, given the significant potential of relapse, the therapy should be considered life-long.

This perspective is echoed by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," akin to managing conditions like hypertension.

Patient Accounts

People who have come off the jabs explain a intense resurgence of hunger.

"It felt as if a switch activating and I was suddenly extremely hungry," recalled an individual.

This difficulty is worsened if users have not adopted permanent lifestyle or habit changes during therapy.

Growing Interest

Survey data suggest that millions of adults in the UK have tried these injections in the past year, with interest being substantial.

• Adoption is greater among women compared to men.
• The middle-aged demographic shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

Finally, clinicians stress that while these medications are effective tools for shedding pounds, they are not a permanent solution and long-term success likely depends on ongoing lifestyle management.